Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Abbott Laboratories, consolidated cash flow statement (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Net Earnings
- Net earnings exhibit significant volatility over the periods. There is a notable peak in December 2024 with an exceptionally high value of 9,229 million USD, followed by a sharp decline thereafter. Other quarters show fluctuations but generally maintain a range between about 500 million and 2,400 million USD, reflecting irregular income patterns with occasional strong quarters.
- Depreciation and Amortization
- Depreciation remains relatively stable, fluctuating modestly between 267 million and 370 million USD, suggesting consistent capital asset usage. Amortization of intangible assets gradually declines from around 561 million USD in early 2020 to about 420 million USD by mid-2025, indicating diminishing intangible asset bases or accelerated amortization schedules over time.
- Share-Based Compensation
- Share-based compensation is highly variable, with several spikes notably in March quarters (e.g., 305 million USD in March 2022 and 304 million USD in March 2024). These periodic increases may relate to annual or quarterly stock compensation grants or settlements.
- Trade Receivables and Inventories
- Trade receivables show considerable swings between positive and negative values. Several quarters reflecting negative figures, especially in 2022 and later periods, suggest reversals or adjustments. Inventories also show large negative swings at times but appear to experience some recovery toward certain later quarters, signifying fluctuations in stock levels and potential supply chain adjustments.
- Other, Net and Adjustments to Reconcile Net Earnings to Operating Cash Flow
- “Other, net” items show strong variability with significant negative spikes such as -7,356 million USD in December 2024, implying extraordinary or nonrecurring events impacting net cash flow. Adjustments to reconcile net earnings to net cash from operating activities fluctuate widely, with sharp negative adjustment in December 2024 (-6,361 million USD), indicating significant non-cash charges or working capital changes in that quarter.
- Net Cash from Operating Activities
- Operating cash flow is generally robust and positive, with most quarters showing inflows ranging from about 700 million to over 3,700 million USD. There is a notable dip in some quarters of 2024 and early 2025, but cash flow remains strong overall, highlighting efficient cash generation from core operations despite earnings volatility.
- Investing Activities
- Cash used in investing activities consistently represents cash outflows mainly related to acquisitions of property, equipment, and occasional business acquisitions. The outflows vary between approximately -300 million to -1,200 million USD, reflecting ongoing capital expenditures and strategic acquisitions. Notable spikes in cash usage occurred in early 2023 and late 2024, likely related to larger investments or acquisitions.
- Financing Activities
- Net cash used in financing activities is often negative, with substantial fluctuations that align with share repurchases and dividend payments. Dividends remain relatively stable around -800 to -1,000 million USD per quarter, indicating consistent shareholder returns. Share buybacks vary considerably, with some quarters showing large purchases (e.g., -2,307 million USD in March 2022), signaling active capital return strategies. Issuance and repayment of debt show irregular, mostly minor flows, except for major repayments in late 2021 and early 2023.
- Effect of Exchange Rate Changes
- This effect is generally minor and fluctuates between modest gains and losses, reflecting normal currency translation impacts on cash balances.
- Net Increase (Decrease) in Cash and Cash Equivalents
- Cash balances demonstrate repeated swings between gains and losses. Several quarters reveal strong cash inflows exceeding 1 billion USD, while others show declines over 1 billion USD. The large negative net cash change in March 2022 and December 2024 correspond with unusual investing and financing outflows, suggesting concentrated expenditures or strategic shifts during these periods.